Racial and Ethnic Disparities in Buprenorphine and Extended-Release Naltrexone Filled Prescriptions During the COVID-19 Pandemic

IMPORTANCE: COVID-19 disrupted delivery of buprenorphine and naltrexone treatment for opioid use disorder (OUD), and during the pandemic, members of racial and ethnic minority groups experienced increased COVID-19 and opioid overdose risks compared with White individuals. However, whether filled bup...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Thuy, Ziedan, Engy, Simon, Kosali, Miles, Jennifer, Crystal, Stephen, Samples, Hillary, Gupta, Sumedha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161014/
https://www.ncbi.nlm.nih.gov/pubmed/35648400
http://dx.doi.org/10.1001/jamanetworkopen.2022.14765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161014/
https://www.ncbi.nlm.nih.gov/pubmed/35648400
http://dx.doi.org/10.1001/jamanetworkopen.2022.14765

Ejemplares similares